Cancer Mutation Improves Chemo Drug Performance

When it comes to cancer biomarkers, it’s often the genetic signatures that are associated with poor patient outcomes that take center stage. Take for example triple-negative breast cancer, a diagnostic marker for a condition that is notoriously difficult to treat and puts patients at significantly higher risks of relapse after therapy.

--

--

--

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

Chances Are, You Had Toxic Lead Levels as a Kid

Just thinking.

Hoy Health: Providing Cash-based Healthcare Solutions for Medically Underserved & Hispanic Families

Healthtech #1: Quin

Late Diagnosis: School Years

Is It Safe to Run Outside During Coronavirus Spread?

Fascinating Truths Linked with Spinal Cord Injury Part No 2

This is what your age reveals about your Coronavirus beliefs

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
River D'Almeida, Ph.D

River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

More from Medium

Aging and Protein Assembly Problems

Humanized Mice Reveal the Origins of Lung Immune Cells

What Sentient Chatbots Could Mean for the Field of Telemedicine

Alzheimer’s Disease And Skin Cancer In The Brain: What They Have In Common